Dr Walter J Coyle, MD | |
10666 N Torrey Pines Rd, La Jolla, CA 92037-1027 | |
(858) 554-8879 | |
(858) 554-8065 |
Full Name | Dr Walter J Coyle |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 38 Years |
Location | 10666 N Torrey Pines Rd, La Jolla, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609847482 | NPI | - | NPPES |
00G877990 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | G87799 (California) | Primary |
207R00000X | Internal Medicine | G87799 (California) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Scripps Green Hospital | La jolla, CA | Hospital |
Scripps Memorial Hospital - Encinitas | Encinitas, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scripps Health | 9234033853 | 1362 |
News Archive
Patrys Limited (ASX: PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Otago researchers are playing a leadership role in an Euro €4.8 million international project to conduct the world's first trial attempting to prevent tuberculosis in people with diabetes.
The recent salmonella outbreak/egg recall is raising questions about whether the FDA is fulfilling its regulatory role, PBS' NewsHour reports. "For the past few years, it's been one food safety scare after another. There was E. coli-laced spinach, salmonella-tainted peppers. ... There have also been problems with drugs. The ingredients in a contaminated blood thinner came from China.
› Verified 9 days ago
Entity Name | Scripps Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
Patrys Limited (ASX: PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Otago researchers are playing a leadership role in an Euro €4.8 million international project to conduct the world's first trial attempting to prevent tuberculosis in people with diabetes.
The recent salmonella outbreak/egg recall is raising questions about whether the FDA is fulfilling its regulatory role, PBS' NewsHour reports. "For the past few years, it's been one food safety scare after another. There was E. coli-laced spinach, salmonella-tainted peppers. ... There have also been problems with drugs. The ingredients in a contaminated blood thinner came from China.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Walter J Coyle, MD 10790 Rancho Bernardo Rd, San Diego, CA 92127-5705 Ph: (858) 554-8879 | Dr Walter J Coyle, MD 10666 N Torrey Pines Rd, La Jolla, CA 92037-1027 Ph: (858) 554-8879 |
News Archive
Patrys Limited (ASX: PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Otago researchers are playing a leadership role in an Euro €4.8 million international project to conduct the world's first trial attempting to prevent tuberculosis in people with diabetes.
The recent salmonella outbreak/egg recall is raising questions about whether the FDA is fulfilling its regulatory role, PBS' NewsHour reports. "For the past few years, it's been one food safety scare after another. There was E. coli-laced spinach, salmonella-tainted peppers. ... There have also been problems with drugs. The ingredients in a contaminated blood thinner came from China.
› Verified 9 days ago
Dr. John Sturdivant Andrews, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1223 Via Barranca, La Jolla, CA 92037 Phone: 858-775-1976 | |
Dr. Mark C Adrian, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 | |
Dr. Erminia M. Guarneri, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-3330 Fax: 858-784-5933 | |
Dr. Eric Hong, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave, Suite 300, La Jolla, CA 92037 Phone: 858-824-2900 Fax: 858-824-2910 | |
Katrina Deleon, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 | |
Abhishek Gadre, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7118 | |
Kamran Hussain Imam, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 |